PHOSPHORAMIDATE PEPTIDE INHIBITORS OF HUMAN-SKIN FIBROBLAST COLLAGENASE

被引:43
|
作者
KORTYLEWICZ, ZP
GALARDY, RE
机构
[1] UNIV KENTUCKY,DEPT BIOCHEM,LEXINGTON,KY 40508
[2] UNIV KENTUCKY,SANDERS BROWN RES CTR AGING,LEXINGTON,KY 40508
关键词
D O I
10.1021/jm00163a044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An extensive series of N-(monoethylphosphoryl)peptides was synthesized and their inhibition of purified human skin fibroblast collagenase examined. At the cleavage site S1all reported compounds have the (EtO)(OK)P(O) group and the peptide side chain extended toward the C-terminal end (up to P6') of the substrate sequence. These phosphoramidates with a tetrahedrally hybridized phosphorus atom are thought to be transition state analogue inhibitors. They exhibited fair inhibitory potency against this vertebrate collagenase having Kt values in the micromolar range. The most potent of these, (EtO)(OK)P(O)-Ile-TrpNHCH3 (68), inhibits with a K1value of 1.5 µM and is nearly 100 times stronger than (EtO)(OK)P(O)Ile-Ala-GlyOK (51) (Kiof 140 µM), which has the sequence matching that of the αi(I) chain of collagen in P1', P2', P3' after the cleavage site. Several compounds were prepared in an attempt to identify the nature of the S2', S3', and S4' binding sites. Alanine at the P2' position was replaced by leucine, phenylalanine, tryptophan, or tyrosine derivatives, resulting in Ki, values in a significantly lower range, 1.0-40 µM, compared to 51. No upper size limitation or specificity has been found at this position, yet similar replacements at the P3' position, which is occupied naturally by a glycine residue, gave weaker inhibitors: (EtO)(OK)P(O)-Ile-Tyr(OBzl)-PheOK (57) had a Kiof 120 µM. Hexapeptide derivatives had weaker activities in the 270 µM-2 mM range. All inhibitors were evaluated by using the synthetic thio peptolide spectrophotometric assay. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:263 / 273
页数:11
相关论文
共 50 条
  • [1] THE HUMAN-SKIN FIBROBLAST COLLAGENASE GENE
    SMITH, J
    COLLIER, I
    KRONBERGER, A
    WILHELM, S
    GOLDBERG, G
    BAUER, EA
    EISEN, AZ
    CLINICAL RESEARCH, 1988, 36 (03): : A696 - A696
  • [2] THE HUMAN-SKIN FIBROBLAST COLLAGENASE GENE
    SMITH, J
    COLLIER, I
    KRONBERGER, A
    WILHELM, S
    GOLDBERG, G
    BAUER, EA
    EISEN, AZ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (04) : 609 - 609
  • [3] THE GELATINOLYTIC ACTIVITY OF HUMAN-SKIN FIBROBLAST COLLAGENASE
    WELGUS, HG
    JEFFREY, JJ
    STRICKLIN, GP
    EISEN, AZ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (19) : 1534 - 1539
  • [4] THE STRUCTURE OF THE HUMAN-SKIN FIBROBLAST COLLAGENASE GENE
    COLLIER, IE
    SMITH, J
    KRONBERGER, A
    BAUER, EA
    WILHELM, SM
    EISEN, AZ
    GOLDBERG, GI
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (22) : 10711 - 10713
  • [5] THE GELATINOLYTIC ACTIVITY OF HUMAN-SKIN FIBROBLAST COLLAGENASE
    WELGUS, HG
    JEFFREY, JJ
    STRICKLIN, GP
    EISEN, AZ
    CLINICAL RESEARCH, 1982, 30 (02): : A266 - A266
  • [6] THE PROTEOLYTIC ACTIVITIES OF HUMAN-SKIN FIBROBLAST COLLAGENASE
    FIELDS, GB
    PIERSON, M
    BIRKEDALHANSEN, H
    VANWART, HE
    FASEB JOURNAL, 1988, 2 (05): : A1006 - A1006
  • [7] PURIFICATION AND CHARACTERIZATION OF HUMAN-SKIN FIBROBLAST COLLAGENASE INHIBITOR
    STRICKLIN, GP
    WELGUS, HG
    CLINICAL RESEARCH, 1983, 31 (02): : A267 - A267
  • [8] HUMAN-SKIN FIBROBLAST COLLAGENASE - INTERACTION WITH SUBSTRATE AND INHIBITOR
    WELGUS, HG
    JEFFREY, JJ
    EISEN, AZ
    ROSWIT, WT
    STRICKLIN, GP
    COLLAGEN AND RELATED RESEARCH, 1985, 5 (02): : 167 - 179
  • [9] CHARACTERISTICS OF THE ACTION OF HUMAN-SKIN FIBROBLAST COLLAGENASE ON FIBRILLAR COLLAGEN
    WELGUS, HG
    JEFFREY, JJ
    STRICKLIN, GP
    ROSWIT, WT
    EISEN, AZ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (14) : 6806 - 6813
  • [10] THE COLLAGEN SUBSTRATE-SPECIFICITY OF HUMAN-SKIN FIBROBLAST COLLAGENASE
    WELGUS, HG
    JEFFREY, JJ
    EISEN, AZ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1981, 256 (18) : 9511 - 9515